Effects of propionyl-L-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart

被引:24
作者
Felix, C
Gillis, M
Driedzic, WR
Paulson, DJ
Broderick, TL
机构
[1] Midwestern Univ, Dept Physiol, Glendale, AZ 85308 USA
[2] Mem Univ Newfoundland, Ctr Ocean Sci, St Johns, NF A1C 5S7, Canada
[3] Dalhousie Univ, Fac Med, Halifax, NS B3H 3J7, Canada
[4] Dalhousie Univ, Fac Med, Dept Pharmacol, Halifax, NS B3H 4H7, Canada
关键词
diabetes; propionyl-L-carnitine; mitochondria; cardiac function; reperfusion;
D O I
10.1016/S0168-8227(01)00240-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of propionyl-L-carnitine (PLC) on isolated mitochondrial respiration in the ischemic reperfused diabetic heart were studied. Oral PLC treatment of STZ-diabetic rats was initiated for a period of 6 weeks. After treatment, isolated working hearts from diabetic rats were perfused under aerobic conditions then subjected to 25 min of no-flow ischemia followed by 15 min of aerobic reperfusion. At the end of reperfusion, heart mitochondria was isolated using differential centrifugation and respiration measured in the presence of pyruvate, glutamate, and palmitoylcarnitine. Our results indicate that diabetes was characterized by a pronounced decrease in heart function under aerobic conditions as well as during reperfusion following ischemia. Treatment with PLC resulted in a significant improve ment in heart function under these conditions. The depressions in state 3 mitochondrial respiration with both pyruvate and glutamate seen in reperfused hearts from diabetic rats were prevented by PLC. State 3 respiration in the presence of palmitoylcarnitine was also improved in the ischemic reperfused diabetic rat heart. Our results show that PLC improves recovery of mechanical function following ischemia in the diabetic rat heart. The beneficial effects of PLC are associated with enhanced mitochondrial oxidation of fuels. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 38 条
[1]   Carnitine and its derivatives in cardiovascular disease [J].
Arsenian, MA .
PROGRESS IN CARDIOVASCULAR DISEASES, 1997, 40 (03) :265-286
[2]   ACUTE IMPROVEMENT OF CARDIAC-FUNCTION WITH INTRAVENOUS L-PROPIONYLCARNITINE IN HUMANS [J].
BARTELS, GL ;
REMME, WJ ;
PILLAY, M ;
SCHONFELD, DHW ;
COX, PH ;
KRUIJSSEN, HACM ;
KNUFMAN, NMJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 (01) :157-164
[3]   CARNITINE - METABOLISM AND FUNCTIONS [J].
BREMER, J .
PHYSIOLOGICAL REVIEWS, 1983, 63 (04) :1420-1480
[4]  
BRODERICK TL, 1995, CARDIOVASC RES, V29, P373, DOI 10.1016/0008-6363(96)88594-4
[5]  
BRODERICK TL, 1992, J BIOL CHEM, V267, P3758
[6]   L-propionylcarnitine enhancement of substrate oxidation and mitochondrial respiration in the diabetic rat heart [J].
Broderick, TL ;
Haloftis, G ;
Paulson, DJ .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (02) :331-340
[7]   ACUTE INSULIN WITHDRAWAL FROM DIABETIC BB RATS DECREASES MYOCARDIAL GLYCOLYSIS DURING LOW-FLOW ISCHEMIA [J].
BRODERICK, TL ;
BARR, RL ;
QUINNEY, HA ;
LOPASCHUK, GD .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (03) :332-338
[8]  
FERRARI R, 1989, MOL CELL BIOCHEM, V88, P161
[9]  
Ferreira JMM, 1997, ASSIST TECHN RES SER, V3, P217
[10]   Controversies on the sensitivity of the diabetic heart to ischemic injury: The sensitivity of the diabetic heart to ischemic injury is decreased [J].
Feuvray, D ;
Lopaschuk, GD .
CARDIOVASCULAR RESEARCH, 1997, 34 (01) :113-120